Olga Tosas Auguet
Overview
Explore the profile of Olga Tosas Auguet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopes C, Kundu D, da Costa Barreto I, da Cruz B, Kumar S, Ramalingam S, et al.
Glob Health Res Policy
. 2022 May;
7(1):16.
PMID: 35590345
Background: A national drug resistance survey (DRS) was implemented for the first time in Timor-Leste (TL) in 2019. The primary objective of the survey was to assess the prevalence of...
2.
Dean A, Auguet O, Glaziou P, Zignol M, Ismail N, Kasaeva T, et al.
Lancet Infect Dis
. 2022 Mar;
22(7):e191-e196.
PMID: 35248168
Tuberculosis is second only to COVID-19 as a cause of death from a single infectious agent. In 2020, almost 10 million people were estimated to have developed tuberculosis and it...
3.
Auguet O, Niehus R, Gweon H, Berkley J, Waichungo J, Njim T, et al.
EClinicalMedicine
. 2021 Jun;
36:100910.
PMID: 34124634
Background: Antimicrobial resistance (AMR) in is a global health threat. Capacity for individual-level surveillance remains limited in many countries, whilst population-level surveillance approaches could inform empiric antibiotic treatment guidelines. Methods:...
4.
Auguet O, Stabler R, Betley J, Preston M, Dhaliwal M, Gaunt M, et al.
Clin Infect Dis
. 2017 Nov;
66(6):840-848.
PMID: 29095965
Background: Recent evidence suggests that hospital transmission of methicillin-resistant Staphylococcus aureus (MRSA) is uncommon in UK centers that have implemented sustained infection control programs. We investigated whether a healthcare-network analysis...
5.
Otter J, Dyakova E, Bisnauthsing K, Querol-Rubiera A, Patel A, Ahanonu C, et al.
J Antimicrob Chemother
. 2016 Aug;
71(12):3556-3561.
PMID: 27516471
Background: Carbapenemase-producing Enterobacteriaceae (CPE) are an emerging threat for healthcare providers worldwide. Objectives: To determine CPE carriage rates and risk factors in an unselected hospital cohort at the time of...
6.
Deeny S, Worby C, Auguet O, Cooper B, Edgeworth J, Cookson B, et al.
Clin Infect Dis
. 2016 Feb;
62(9):1193-4.
PMID: 26908798
No abstract available.
7.
Auguet O, Betley J, Stabler R, Patel A, Ioannou A, Marbach H, et al.
PLoS Med
. 2016 Jan;
13(1):e1001944.
PMID: 26812054
Background: Identifying and tackling the social determinants of infectious diseases has become a public health priority following the recognition that individuals with lower socioeconomic status are disproportionately affected by infectious...
8.
Woolhouse M, Thumbi S, Jennings A, Chase-Topping M, Callaby R, Kiara H, et al.
Sci Adv
. 2015 Nov;
1(2):e1400026.
PMID: 26601143
Many individual hosts are infected with multiple parasite species, and this may increase or decrease the pathogenicity of the infections. This phenomenon is termed heterologous reactivity and is potentially an...
9.
Deeny S, Worby C, Auguet O, Cooper B, Edgeworth J, Cookson B, et al.
J Antimicrob Chemother
. 2015 Sep;
70(12):3366-78.
PMID: 26338047
Objectives: The objectives of this study were to estimate the relative transmissibility of mupirocin-resistant (MupR) and mupirocin-susceptible (MupS) MRSA strains and evaluate the long-term impact of MupR on MRSA control...
10.
Hughes J, Stabler R, Gaunt M, Karadag T, Desai N, Betley J, et al.
J Antimicrob Chemother
. 2015 Aug;
70(12):3191-9.
PMID: 26316381
Objectives: Both low-level mupirocin resistance (LMR) and high-level mupirocin resistance (HMR) have been identified. The aim of this study was to determine the epidemiology of LMR and HMR in MRSA...